{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:00:53Z","timestamp":1793829653783,"version":"4.6.1"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T00:00:00Z","timestamp":1597017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T00:00:00Z","timestamp":1597017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R15NS112964"],"award-info":[{"award-number":["R15NS112964"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Brain"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The dopamine (DA) system has a profound impact on reward-motivated behavior and is critically involved in neurodevelopmental disorders, such as autism spectrum disorder (ASD). Although DA defects are found in autistic patients, it is not well defined how the DA pathways are altered in ASD and whether DA can be utilized as a potential therapeutic agent for ASD. To this end, we employed a phenotypic and a genetic ASD model, i.e., Black and Tan BRachyury T\n                    <jats:sup>+<\/jats:sup>\n                    Itpr3\n                    <jats:sup>tf<\/jats:sup>\n                    \/J (BTBR) mice and Fragile X Mental Retardation 1 knockout (\n                    <jats:italic>Fmr1<\/jats:italic>\n                    -KO) mice, respectively. Immunostaining of tyrosine hydroxylase (TH) to mark dopaminergic neurons revealed an overall reduction in the TH expression in the substantia nigra, ventral tegmental area and dorsal striatum of BTBR mice, as compared to C57BL\/6\u2009J wild-type ones. In contrast,\n                    <jats:italic>Fmr1<\/jats:italic>\n                    -KO animals did not show such an alteration but displayed abnormal morphology of TH-positive axons in the striatum with higher \u201ccomplexity\u201d and lower \u201ctexture\u201d. Both strains exhibited decreased expression of striatal dopamine transporter (DAT) and increased spatial coupling between vesicular glutamate transporter 1 (VGLUT1, a label for glutamatergic terminals) and TH signals, while GABAergic neurons quantified by glutamic acid decarboxylase 67 (GAD67) remained intact. Intranasal administration of DA rescued the deficits in non-selective attention, object-based attention and social approaching of BTBR mice, likely by enhancing the level of TH in the striatum. Application of intranasal DA to\n                    <jats:italic>Fmr1-<\/jats:italic>\n                    KO animals alleviated their impairment of social novelty, in association with reduced striatal TH protein. These results suggest that although the DA system is modified differently in the two ASD models, intranasal treatment with DA effectively rectifies their behavioral phenotypes, which may present a promising therapy for diverse types of ASD.\n                  <\/jats:p>","DOI":"10.1186\/s13041-020-00649-7","type":"journal-article","created":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T13:03:48Z","timestamp":1597064628000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Altered dopaminergic pathways and therapeutic effects of intranasal dopamine in two distinct mouse models of autism"],"prefix":"10.1186","volume":"13","author":[{"given":"Owen Y.","family":"Chao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salil S.","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Dunaway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay-Shake","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Mattern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Nikolaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph P.","family":"Huston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1491-8106","authenticated-orcid":false,"given":"Yi-Mei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,10]]},"reference":[{"issue":"9920","key":"649_CR1","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(13)61539-1","volume":"383","author":"MC Lai","year":"2014","unstructured":"Lai MC, Lombardo MV, Baron-Cohen S. Autism. Lancet. 2014;383(9920):896\u2013910.","journal-title":"Lancet"},{"issue":"8","key":"649_CR2","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1097\/CHI.0b013e318179964f","volume":"47","author":"E Simonoff","year":"2008","unstructured":"Simonoff E, Pickles A, Charman T, Chandler S, Loucas T, Baird G. Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample. J Am Acad Child Adolesc Psychiatry. 2008;47(8):921\u20139.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"6376","key":"649_CR3","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1126\/science.aad6469","volume":"359","author":"MJ Gandal","year":"2018","unstructured":"Gandal MJ, Haney JR, Parikshak NN, Leppa V, Ramaswami G, Hartl C, Schork AJ, Appadurai V, Buil A, Werge TM, et al. Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap. Science. 2018;359(6376):693\u20137.","journal-title":"Science"},{"issue":"5","key":"649_CR4","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.neuron.2010.11.022","volume":"68","author":"ES Bromberg-Martin","year":"2010","unstructured":"Bromberg-Martin ES, Matsumoto M, Hikosaka O. Dopamine in motivational control: rewarding, aversive, and alerting. Neuron. 2010;68(5):815\u201334.","journal-title":"Neuron"},{"issue":"8","key":"649_CR5","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1001\/archpsyc.64.8.932","volume":"64","author":"ND Volkow","year":"2007","unstructured":"Volkow ND, Wang GJ, Newcorn J, Telang F, Solanto MV, Fowler JS, Logan J, Ma Y, Schulz K, Pradhan K, et al. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit\/hyperactivity disorder. Arch Gen Psychiatry. 2007;64(8):932\u201340.","journal-title":"Arch Gen Psychiatry"},{"issue":"8","key":"649_CR6","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/j.1399-5618.2009.00760.x","volume":"11","author":"DA Cousins","year":"2009","unstructured":"Cousins DA, Butts K, Young AH. The role of dopamine in bipolar disorder. Bipolar Disord. 2009;11(8):787\u2013806.","journal-title":"Bipolar Disord"},{"issue":"1","key":"649_CR7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/sj.mp.4001558","volume":"10","author":"PJ Harrison","year":"2005","unstructured":"Harrison PJ, Weinberger DR. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry. 2005;10(1):40\u201368 image 45.","journal-title":"Mol Psychiatry"},{"issue":"12","key":"649_CR8","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1038\/mp.2013.102","volume":"18","author":"PJ Hamilton","year":"2013","unstructured":"Hamilton PJ, Campbell NG, Sharma S, Erreger K, Herborg Hansen F, Saunders C, Belovich AN, Consortium NAAS, Sahai MA, Cook EH, et al. De novo mutation in the dopamine transporter gene associates dopamine dysfunction with autism spectrum disorder. Mol Psychiatry. 2013;18(12):1315\u201323.","journal-title":"Mol Psychiatry"},{"issue":"3","key":"649_CR9","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.biopsych.2005.03.040","volume":"58","author":"E Hollander","year":"2005","unstructured":"Hollander E, Anagnostou E, Chaplin W, Esposito K, Haznedar MM, Licalzi E, Wasserman S, Soorya L, Buchsbaum M. Striatal volume on magnetic resonance imaging and repetitive behaviors in autism. Biol Psychiatry. 2005;58(3):226\u201332.","journal-title":"Biol Psychiatry"},{"issue":"4","key":"649_CR10","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.biopsych.2009.03.017","volume":"66","author":"M Langen","year":"2009","unstructured":"Langen M, Schnack HG, Nederveen H, Bos D, Lahuis BE, de Jonge MV, van Engeland H, Durston S. Changes in the developmental trajectories of striatum in autism. Biol Psychiatry. 2009;66(4):327\u201333.","journal-title":"Biol Psychiatry"},{"key":"649_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3389\/fnins.2016.00027","volume":"10","author":"MV Fuccillo","year":"2016","unstructured":"Fuccillo MV. Striatal circuits as a common node for autism pathophysiology. Front Neurosci. 2016;10:27.","journal-title":"Front Neurosci"},{"issue":"5 Pt 2","key":"649_CR12","doi-asserted-by":"publisher","first-page":"34R","DOI":"10.1203\/PDR.0b013e318212b80f","volume":"69","author":"PH Patterson","year":"2011","unstructured":"Patterson PH. Modeling autistic features in animals. Pediatr Res. 2011;69(5 Pt 2):34R\u201340R.","journal-title":"Pediatr Res"},{"key":"649_CR13","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neubiorev.2015.02.002","volume":"52","author":"NR Zurcher","year":"2015","unstructured":"Zurcher NR, Bhanot A, McDougle CJ, Hooker JM. A systematic review of molecular imaging (PET and SPECT) in autism spectrum disorder: current state and future research opportunities. Neurosci Biobehav Rev. 2015;52:56\u201373.","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"649_CR14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/acps.12644","volume":"135","author":"K Jobski","year":"2017","unstructured":"Jobski K, Hofer J, Hoffmann F, Bachmann C. Use of psychotropic drugs in patients with autism spectrum disorders: a systematic review. Acta Psychiatr Scand. 2017;135(1):8\u201328.","journal-title":"Acta Psychiatr Scand"},{"issue":"2","key":"649_CR15","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1601-183X.2007.00330.x","volume":"7","author":"HG McFarlane","year":"2008","unstructured":"McFarlane HG, Kusek GK, Yang M, Phoenix JL, Bolivar VJ, Crawley JN. Autism-like behavioral phenotypes in BTBR T+tf\/J mice. Genes Brain Behav. 2008;7(2):152\u201363.","journal-title":"Genes Brain Behav"},{"key":"649_CR16","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.bbr.2018.03.014","volume":"347","author":"OY Chao","year":"2018","unstructured":"Chao OY, Yunger R, Yang YM. Behavioral assessments of BTBR T+Itpr3tf\/J mice by tests of object attention and elevated open platform: implications for an animal model of psychiatric comorbidity in autism. Behav Brain Res. 2018;347:140\u20137.","journal-title":"Behav Brain Res"},{"key":"649_CR17","doi-asserted-by":"crossref","unstructured":"Chao OY, Marron Fernandez de Velasco E, Pathak SS, Maitra S, Zhang H, Duvick L, Wickman K, Orr HT, Hirai H, Yang YM. Targeting inhibitory cerebellar circuitry to alleviate behavioral deficits in a mouse model for studying idiopathic autism. Neuropsychopharmacology. 2020;45:1159\u201370. PMID: 32179875.","DOI":"10.1038\/s41386-020-0656-5"},{"issue":"10","key":"649_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076655","volume":"8","author":"L Dodero","year":"2013","unstructured":"Dodero L, Damiano M, Galbusera A, Bifone A, Tsaftsaris SA, Scattoni ML, Gozzi A. Neuroimaging evidence of major morpho-anatomical and functional abnormalities in the BTBR T+TF\/J mouse model of autism. PLoS One. 2013;8(10):e76655.","journal-title":"PLoS One"},{"key":"649_CR19","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.neuroimage.2012.12.029","volume":"70","author":"J Ellegood","year":"2013","unstructured":"Ellegood J, Babineau BA, Henkelman RM, Lerch JP, Crawley JN. Neuroanatomical analysis of the BTBR mouse model of autism using magnetic resonance imaging and diffusion tensor imaging. Neuroimage. 2013;70:288\u2013300.","journal-title":"Neuroimage"},{"key":"649_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2014.69","volume":"4","author":"M Squillace","year":"2014","unstructured":"Squillace M, Dodero L, Federici M, Migliarini S, Errico F, Napolitano F, Krashia P, Di Maio A, Galbusera A, Bifone A, et al. Dysfunctional dopaminergic neurotransmission in asocial BTBR mice. Transl Psychiatry. 2014;4:e427.","journal-title":"Transl Psychiatry"},{"issue":"1","key":"649_CR21","first-page":"23","volume":"78","author":"CE Bakker","year":"1994","unstructured":"Bakker CE, Verheij C, Wilemsen R, van der Helm R, Oerlemans F, Vermey M, Bygrave A, Hoogeveen A, Oostra BA, Reyniers E, et al. Fmr1 knockout mice: a model to study fragile X mental retardation. Cell. 1994;78(1):23\u201333.","journal-title":"Cell"},{"issue":"6","key":"649_CR22","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1352\/2008.113:427-438","volume":"113","author":"SW Harris","year":"2008","unstructured":"Harris SW, Hessl D, Goodlin-Jones B, Ferranti J, Bacalman S, Barbato I, Tassone F, Hagerman PJ, Herman H, Hagerman RJ. Autism profiles of males with fragile X syndrome. Am J Ment Retard. 2008;113(6):427\u201338.","journal-title":"Am J Ment Retard"},{"issue":"10","key":"649_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0077896","volume":"8","author":"EW Fish","year":"2013","unstructured":"Fish EW, Krouse MC, Stringfield SJ, Diberto JF, Robinson JE, Malanga CJ. Changes in sensitivity of reward and motor behavior to dopaminergic, glutamatergic, and cholinergic drugs in a mouse model of fragile X syndrome. PLoS One. 2013;8(10):e77896.","journal-title":"PLoS One"},{"issue":"10","key":"649_CR24","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1021\/cn100032f","volume":"1","author":"JL Fulks","year":"2010","unstructured":"Fulks JL, O'Bryhim BE, Wenzel SK, Fowler SC, Vorontsova E, Pinkston JW, Ortiz AN, Johnson MA. Dopamine release and uptake impairments and behavioral alterations observed in mice that model fragile X mental retardation syndrome. ACS Chem Neurosci. 2010;1(10):679\u201390.","journal-title":"ACS Chem Neurosci"},{"issue":"4","key":"649_CR25","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.neuron.2008.06.027","volume":"59","author":"H Wang","year":"2008","unstructured":"Wang H, Wu LJ, Kim SS, Lee FJ, Gong B, Toyoda H, Ren M, Shang YZ, Xu H, Liu F, et al. FMRP acts as a key messenger for dopamine modulation in the forebrain. Neuron. 2008;59(4):634\u201347.","journal-title":"Neuron"},{"issue":"4","key":"649_CR26","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1113\/jphysiol.2012.241067","volume":"591","author":"K Paul","year":"2013","unstructured":"Paul K, Venkitaramani DV, Cox CL. Dampened dopamine-mediated neuromodulation in prefrontal cortex of fragile X mice. J Physiol. 2013;591(4):1133\u201343.","journal-title":"J Physiol"},{"issue":"Pt A","key":"649_CR27","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.neubiorev.2016.12.037","volume":"76","author":"KZ Meyza","year":"2017","unstructured":"Meyza KZ, Blanchard DC. The BTBR mouse model of idiopathic autism - Current view on mechanisms. Neurosci Biobehav Rev. 2017;76(Pt A):99\u2013110.","journal-title":"Neurosci Biobehav Rev"},{"issue":"6","key":"649_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss6706a1","volume":"67","author":"J Baio","year":"2018","unstructured":"Baio J, Wiggins L, Christensen DL, Maenner MJ, Daniels J, Warren Z, Kurzius-Spencer M, Zahorodny W, Robinson Rosenberg C, White T, et al. Prevalence of autism Spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2014. MMWR Surveill Summ. 2018;67(6):1\u201323.","journal-title":"MMWR Surveill Summ"},{"key":"649_CR29","unstructured":"Franklin KBJ, Paxinos G. The mouse brain in stereotaxic coordinates, compact third edition. 3rd ed: Academic Press; 2008. ISBN: 9780123742445. ISBN: 9780080921365."},{"issue":"1\u20132","key":"649_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0165-0270(98)00021-1","volume":"81","author":"HF Jelinek","year":"1998","unstructured":"Jelinek HF, Fernandez E. Neurons and fractals: how reliable and useful are calculations of fractal dimensions? J Neurosci Methods. 1998;81(1\u20132):9\u201318.","journal-title":"J Neurosci Methods"},{"key":"649_CR31","doi-asserted-by":"publisher","first-page":"8967902","DOI":"10.1155\/2017\/8967902","volume":"2017","author":"N Rajkovic","year":"2017","unstructured":"Rajkovic N, Krstonosic B, Milosevic N. Box-counting method of 2D neuronal image: method modification and quantitative analysis demonstrated on images from the monkey and human brain. Comput Math Methods Med. 2017;2017:8967902.","journal-title":"Comput Math Methods Med"},{"key":"649_CR32","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/978-1-59745-257-1_29","volume":"362","author":"C Lee","year":"2007","unstructured":"Lee C. Protein extraction from mammalian tissues. Methods Mol Biol. 2007;362:385\u20139.","journal-title":"Methods Mol Biol"},{"key":"649_CR33","doi-asserted-by":"publisher","unstructured":"Yang YM, Arsenault J, Bah A, Krzeminski M, Fekete A, Chao OY, Pacey LK, Wang A, Forman-Kay J, Hampson DR, et al. Identification of a molecular locus for normalizing dysregulated GABA release from interneurons in the fragile X brain. Mol Psychiatry. 2018. https:\/\/doi.org\/10.1038\/s41380-018-0240-0.","DOI":"10.1038\/s41380-018-0240-0"},{"key":"649_CR34","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s11055-013-9747-7","volume":"43","author":"A Kholodar","year":"2013","unstructured":"Kholodar A, Amikishieva A, Anisimov M. Effects of intranasal administration of dopamine on anxiety and locomotor activity in two mouse strains. Neurosci Behav Physiol. 2013;43:409\u201315.","journal-title":"Neurosci Behav Physiol"},{"issue":"2","key":"649_CR35","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/nprot.2007.44","volume":"2","author":"AA Walf","year":"2007","unstructured":"Walf AA, Frye CA. The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat Protoc. 2007;2(2):322\u20138.","journal-title":"Nat Protoc"},{"issue":"1","key":"649_CR36","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0166-4328(97)00217-9","volume":"95","author":"R Aspide","year":"1998","unstructured":"Aspide R, Gironi Carnevale UA, Sergeant JA, Sadile AG. Non-selective attention and nitric oxide in putative animal models of attention-deficit hyperactivity disorder. Behav Brain Res. 1998;95(1):123\u201333.","journal-title":"Behav Brain Res"},{"issue":"1","key":"649_CR37","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nrn.2015.8","volume":"17","author":"AV Kalueff","year":"2016","unstructured":"Kalueff AV, Stewart AM, Song C, Berridge KC, Graybiel AM, Fentress JC. Neurobiology of rodent self-grooming and its value for translational neuroscience. Nat Rev Neurosci. 2016;17(1):45\u201359.","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"649_CR38","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1037\/0735-7044.104.3.470","volume":"104","author":"H Milani","year":"1990","unstructured":"Milani H, Schwarting RK, Kumpf S, Steiner H, Huston JP. Interaction between recovery from behavioral asymmetries induced by hemivibrissotomy in the rat and the effects of apomorphine and amphetamine. Behav Neurosci. 1990;104(3):470\u20136.","journal-title":"Behav Neurosci"},{"issue":"1","key":"649_CR39","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0166-4328(94)90008-6","volume":"61","author":"P Simon","year":"1994","unstructured":"Simon P, Dupuis R, Costentin J. Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions. Behav Brain Res. 1994;61(1):59\u201364.","journal-title":"Behav Brain Res"},{"issue":"1\u20133","key":"649_CR40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","volume":"463","author":"L Prut","year":"2003","unstructured":"Prut L, Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol. 2003;463(1\u20133):3\u201333.","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"649_CR41","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/nrn2851","volume":"11","author":"JL Silverman","year":"2010","unstructured":"Silverman JL, Yang M, Lord C, Crawley JN. Behavioural phenotyping assays for mouse models of autism. Nat Rev Neurosci. 2010;11(7):490\u2013502.","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"649_CR42","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0896-6273(01)00344-0","volume":"31","author":"RT Fremeau Jr","year":"2001","unstructured":"Fremeau RT Jr, Troyer MD, Pahner I, Nygaard GO, Tran CH, Reimer RJ, Bellocchio EE, Fortin D, Storm-Mathisen J, Edwards RH. The expression of vesicular glutamate transporters defines two classes of excitatory synapse. Neuron. 2001;31(2):247\u201360.","journal-title":"Neuron"},{"issue":"10","key":"649_CR43","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1111\/j.1460-9568.2006.05177.x","volume":"24","author":"F Fujiyama","year":"2006","unstructured":"Fujiyama F, Unzai T, Nakamura K, Nomura S, Kaneko T. Difference in organization of corticostriatal and thalamostriatal synapses between patch and matrix compartments of rat neostriatum. Eur J Neurosci. 2006;24(10):2813\u201324.","journal-title":"Eur J Neurosci"},{"issue":"44","key":"649_CR44","doi-asserted-by":"publisher","first-page":"11221","DOI":"10.1523\/JNEUROSCI.2780-08.2008","volume":"28","author":"J Moss","year":"2008","unstructured":"Moss J, Bolam JP. A dopaminergic axon lattice in the striatum and its relationship with cortical and thalamic terminals. J Neurosci. 2008;28(44):11221\u201330.","journal-title":"J Neurosci"},{"key":"649_CR45","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1146\/annurev.neuro.051508.135422","volume":"32","author":"AC Kreitzer","year":"2009","unstructured":"Kreitzer AC. Physiology and pharmacology of striatal neurons. Annu Rev Neurosci. 2009;32:127\u201347.","journal-title":"Annu Rev Neurosci"},{"issue":"4","key":"649_CR46","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1002\/jps.21924","volume":"99","author":"SV Dhuria","year":"2010","unstructured":"Dhuria SV, Hanson LR, Frey WH 2nd. Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J Pharm Sci. 2010;99(4):1654\u201373.","journal-title":"J Pharm Sci"},{"issue":"10","key":"649_CR47","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.tips.2008.07.005","volume":"29","author":"A Ramos","year":"2008","unstructured":"Ramos A. Animal models of anxiety: do I need multiple tests? Trends Pharmacol Sci. 2008;29(10):493\u20138.","journal-title":"Trends Pharmacol Sci"},{"issue":"5\u20136","key":"649_CR48","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/00008877-200409000-00018","volume":"15","author":"R Ventura","year":"2004","unstructured":"Ventura R, Pascucci T, Catania MV, Musumeci SA, Puglisi-Allegra S. Object recognition impairment in Fmr1 knockout mice is reversed by amphetamine: involvement of dopamine in the medial prefrontal cortex. Behav Pharmacol. 2004;15(5\u20136):433\u201342.","journal-title":"Behav Pharmacol"},{"key":"649_CR49","doi-asserted-by":"crossref","unstructured":"Sorensen EM, Bertelsen F, Weikop P, Skovborg MM, Banke T, Drasbek KR, Scheel-Kruger J. Hyperactivity and lack of social discrimination in the adolescent Fmr1 knockout mouse. Behav Pharmacol. 2015; 26(8 Spec No):733\u2013740.","DOI":"10.1097\/FBP.0000000000000152"},{"issue":"5","key":"649_CR50","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1002\/brb3.273","volume":"4","author":"L Martin","year":"2014","unstructured":"Martin L, Sample H, Gregg M, Wood C. Validation of operant social motivation paradigms using BTBR T+tf\/J and C57BL\/6J inbred mouse strains. Brain Behav. 2014;4(5):754\u201364.","journal-title":"Brain Behav"},{"issue":"1","key":"649_CR51","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.bbr.2012.04.040","volume":"233","author":"BL Pearson","year":"2012","unstructured":"Pearson BL, Bettis JK, Meyza KZ, Yamamoto LY, Blanchard DC, Blanchard RJ. Absence of social conditioned place preference in BTBR T+tf\/J mice: relevance for social motivation testing in rodent models of autism. Behav Brain Res. 2012;233(1):99\u2013104.","journal-title":"Behav Brain Res"},{"issue":"6","key":"649_CR52","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.neuron.2019.02.041","volume":"101","author":"C Bagni","year":"2019","unstructured":"Bagni C, Zukin RS. A synaptic perspective of fragile X syndrome and autism spectrum disorders. Neuron. 2019;101(6):1070\u201388.","journal-title":"Neuron"},{"issue":"6","key":"649_CR53","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/S0896-6273(02)00731-6","volume":"34","author":"J Morales","year":"2002","unstructured":"Morales J, Hiesinger PR, Schroeder AJ, Kume K, Verstreken P, Jackson FR, Nelson DL, Hassan BA. Drosophila fragile X protein, DFXR, regulates neuronal morphology and function in the brain. Neuron. 2002;34(6):961\u201372.","journal-title":"Neuron"},{"issue":"6","key":"649_CR54","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/S0896-6273(02)00724-9","volume":"34","author":"TC Dockendorff","year":"2002","unstructured":"Dockendorff TC, Su HS, McBride SM, Yang Z, Choi CH, Siwicki KK, Sehgal A, Jongens TA. Drosophila lacking dfmr1 activity show defects in circadian output and fail to maintain courtship interest. Neuron. 2002;34(6):973\u201384.","journal-title":"Neuron"},{"issue":"20","key":"649_CR55","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1016\/j.cub.2004.09.085","volume":"14","author":"L Pan","year":"2004","unstructured":"Pan L, Zhang YQ, Woodruff E, Broadie K. The Drosophila fragile X gene negatively regulates neuronal elaboration and synaptic differentiation. Curr Biol. 2004;14(20):1863\u201370.","journal-title":"Curr Biol"},{"issue":"6","key":"649_CR56","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/dneu.22453","volume":"77","author":"SE Zimmer","year":"2017","unstructured":"Zimmer SE, Doll SG, Garcia ADR, Akins MR. Splice form-dependent regulation of axonal arbor complexity by FMRP. Dev Neurobiol. 2017;77(6):738\u201352.","journal-title":"Dev Neurobiol"},{"issue":"12","key":"649_CR57","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1038\/nn.3870","volume":"17","author":"G La Fata","year":"2014","unstructured":"La Fata G, Gartner A, Dominguez-Iturza N, Dresselaers T, Dawitz J, Poorthuis RB, Averna M, Himmelreich U, Meredith RM, Achsel T, et al. FMRP regulates multipolar to bipolar transition affecting neuronal migration and cortical circuitry. Nat Neurosci. 2014;17(12):1693\u2013700.","journal-title":"Nat Neurosci"},{"key":"649_CR58","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jpsychires.2018.10.014","volume":"107","author":"GM Sandoval","year":"2018","unstructured":"Sandoval GM, Shim S, Hong DS, Garrett AS, Quintin EM, Marzelli MJ, Patnaik S, Lightbody AA, Reiss AL. Neuroanatomical abnormalities in fragile X syndrome during the adolescent and young adult years. J Psychiatr Res. 2018;107:138\u201344.","journal-title":"J Psychiatr Res"},{"key":"649_CR59","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.mcn.2013.07.009","volume":"56","author":"A Giampetruzzi","year":"2013","unstructured":"Giampetruzzi A, Carson JH, Barbarese E. FMRP and myelin protein expression in oligodendrocytes. Mol Cell Neurosci. 2013;56:333\u201341.","journal-title":"Mol Cell Neurosci"},{"issue":"19","key":"649_CR60","doi-asserted-by":"publisher","first-page":"3920","DOI":"10.1093\/hmg\/ddt246","volume":"22","author":"LK Pacey","year":"2013","unstructured":"Pacey LK, Xuan IC, Guan S, Sussman D, Henkelman RM, Chen Y, Thomsen C, Hampson DR. Delayed myelination in a mouse model of fragile X syndrome. Hum Mol Genet. 2013;22(19):3920\u201330.","journal-title":"Hum Mol Genet"},{"key":"649_CR61","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.brainres.2014.11.023","volume":"1596","author":"S Gholizadeh","year":"2015","unstructured":"Gholizadeh S, Halder SK, Hampson DR. Expression of fragile X mental retardation protein in neurons and glia of the developing and adult mouse brain. Brain Res. 2015;1596:22\u201330.","journal-title":"Brain Res"},{"issue":"5","key":"649_CR62","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.tins.2007.03.008","volume":"30","author":"DJ Surmeier","year":"2007","unstructured":"Surmeier DJ, Ding J, Day M, Wang Z, Shen W. D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons. Trends Neurosci. 2007;30(5):228\u201335.","journal-title":"Trends Neurosci"},{"issue":"6566","key":"649_CR63","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/379606a0","volume":"379","author":"B Giros","year":"1996","unstructured":"Giros B, Jaber M, Jones SR, Wightman RM, Caron MG. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature. 1996;379(6566):606\u201312.","journal-title":"Nature"},{"key":"649_CR64","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.neuropharm.2012.07.042","volume":"68","author":"JL Silverman","year":"2013","unstructured":"Silverman JL, Babineau BA, Oliver CF, Karras MN, Crawley JN. Influence of stimulant-induced hyperactivity on social approach in the BTBR mouse model of autism. Neuropharmacology. 2013;68:210\u201322.","journal-title":"Neuropharmacology"},{"issue":"3","key":"649_CR65","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/syn.20484","volume":"62","author":"MA de Souza Silva","year":"2008","unstructured":"de Souza Silva MA, Topic B, Huston JP, Mattern C. Intranasal dopamine application increases dopaminergic activity in the neostriatum and nucleus accumbens and enhances motor activity in the open field. Synapse. 2008;62(3):176\u201384.","journal-title":"Synapse"},{"key":"649_CR66","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.bbr.2017.07.028","volume":"334","author":"E Janenaite","year":"2017","unstructured":"Janenaite E, Vengeliene V, Bespalov A, Behl B. Potential role of tyrosine hydroxylase in the loss of psychostimulant effect of amphetamine under conditions of impaired dopamine transporter activity. Behav Brain Res. 2017;334:105\u20138.","journal-title":"Behav Brain Res"},{"key":"649_CR67","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fnsyn.2018.00022","volume":"10","author":"J Khlghatyan","year":"2018","unstructured":"Khlghatyan J, Beaulieu JM. Are FXR family proteins integrators of dopamine signaling and glutamatergic neurotransmission in mental illnesses? Front Synaptic Neurosci. 2018;10:22.","journal-title":"Front Synaptic Neurosci"},{"issue":"9","key":"649_CR68","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1007\/s00726-014-1753-8","volume":"46","author":"LA Ruocco","year":"2014","unstructured":"Ruocco LA, Treno C, Gironi Carnevale UA, Arra C, Mattern C, Huston JP, de Souza Silva MA, Nikolaus S, Scorziello A, Nieddu M, et al. Prepuberal intranasal dopamine treatment in an animal model of ADHD ameliorates deficient spatial attention, working memory, amino acid transmitters and synaptic markers in prefrontal cortex, ventral and dorsal striatum. Amino Acids. 2014;46(9):2105\u201322.","journal-title":"Amino Acids"},{"key":"649_CR69","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fnbeh.2016.00080","volume":"10","author":"MA de Souza Silva","year":"2016","unstructured":"de Souza Silva MA, Mattern C, Decheva C, Huston JP, Sadile AG, Beu M, Muller HW, Nikolaus S. Intranasal dopamine reduces in vivo [(123) I]FP-CIT binding to striatal dopamine transporter: correlation with behavioral changes and evidence for Pavlovian conditioned dopamine response. Front Behav Neurosci. 2016;10:80.","journal-title":"Front Behav Neurosci"},{"issue":"1","key":"649_CR70","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0928-0987(01)00151-8","volume":"14","author":"M Dahlin","year":"2001","unstructured":"Dahlin M, Jansson B, Bjork E. Levels of dopamine in blood and brain following nasal administration to rats. Eur J Pharm Sci. 2001;14(1):75\u201380.","journal-title":"Eur J Pharm Sci"},{"issue":"1\u20132","key":"649_CR71","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1159\/000135640","volume":"57","author":"TE Buddenberg","year":"2008","unstructured":"Buddenberg TE, Topic B, Mahlberg ED, de Souza Silva MA, Huston JP, Mattern C. Behavioral actions of intranasal application of dopamine: effects on forced swimming, elevated plus-maze and open field parameters. Neuropsychobiology. 2008;57(1\u20132):70\u20139.","journal-title":"Neuropsychobiology"},{"issue":"6","key":"649_CR72","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1177\/0269881116686882","volume":"31","author":"T Talbot","year":"2017","unstructured":"Talbot T, Mattern C, de Souza Silva MA, Brandao ML. Intranasal administration of dopamine attenuates unconditioned fear in that it reduces restraint-induced ultrasound vocalizations and escape from bright light. J Psychopharmacol. 2017;31(6):682\u201390.","journal-title":"J Psychopharmacol"},{"issue":"1","key":"649_CR73","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.neuroscience.2009.04.051","volume":"162","author":"ME Pum","year":"2009","unstructured":"Pum ME, Schable S, Harooni HE, Topic B, De Souza Silva MA, Li JS, Huston JP, Mattern C. Effects of intranasally applied dopamine on behavioral asymmetries in rats with unilateral 6-hydroxydopamine lesions of the nigro-striatal tract. Neuroscience. 2009;162(1):174\u201383.","journal-title":"Neuroscience"},{"key":"649_CR74","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.nlm.2014.07.006","volume":"114","author":"SV Trossbach","year":"2014","unstructured":"Trossbach SV, de Souza Silva MA, Huston JP, Korth C, Mattern C. Intranasal dopamine treatment reinstates object-place memory in aged rats. Neurobiol Learn Mem. 2014;114:231\u20135.","journal-title":"Neurobiol Learn Mem"},{"key":"649_CR75","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.pbb.2019.02.005","volume":"179","author":"AL Wang","year":"2019","unstructured":"Wang AL, Chao OY, Yang YM, Trossbach SV, Muller CP, Korth C, Huston JP, de Souza Silva MA. Anxiogenic-like behavior and deficient attention\/working memory in rats expressing the human DISC1 gene. Pharmacol Biochem Behav. 2019;179:73\u20139.","journal-title":"Pharmacol Biochem Behav"},{"issue":"10","key":"649_CR76","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.euroneuro.2009.02.005","volume":"19","author":"LA Ruocco","year":"2009","unstructured":"Ruocco LA, de Souza Silva MA, Topic B, Mattern C, Huston JP, Sadile AG. Intranasal application of dopamine reduces activity and improves attention in Naples high excitability rats that feature the mesocortical variant of ADHD. Eur Neuropsychopharmacol. 2009;19(10):693\u2013701.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"7344","key":"649_CR77","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nature09965","volume":"472","author":"J Peca","year":"2011","unstructured":"Peca J, Feliciano C, Ting JT, Wang W, Wells MF, Venkatraman TN, Lascola CD, Fu Z, Feng G. Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature. 2011;472(7344):437\u201342.","journal-title":"Nature"},{"issue":"2","key":"649_CR78","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.cortex.2011.05.018","volume":"48","author":"M Langen","year":"2012","unstructured":"Langen M, Leemans A, Johnston P, Ecker C, Daly E, Murphy CM, Dell'acqua F, Durston S, Consortium A, Murphy DG. Fronto-striatal circuitry and inhibitory control in autism: findings from diffusion tensor imaging tractography. Cortex. 2012;48(2):183\u201393.","journal-title":"Cortex"},{"key":"649_CR79","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3389\/fnhum.2013.00430","volume":"7","author":"S Delmonte","year":"2013","unstructured":"Delmonte S, Gallagher L, O'Hanlon E, McGrath J, Balsters JH. Functional and structural connectivity of frontostriatal circuitry in autism spectrum disorder. Front Hum Neurosci. 2013;7:430.","journal-title":"Front Hum Neurosci"},{"issue":"5","key":"649_CR80","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1159\/000478725","volume":"39","author":"D Paval","year":"2017","unstructured":"Paval D. A dopamine hypothesis of autism spectrum disorder. Dev Neurosci. 2017;39(5):355\u201360.","journal-title":"Dev Neurosci"}],"container-title":["Molecular Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-020-00649-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13041-020-00649-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-020-00649-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T06:14:55Z","timestamp":1650521695000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularbrain.biomedcentral.com\/articles\/10.1186\/s13041-020-00649-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,10]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["649"],"URL":"https:\/\/doi.org\/10.1186\/s13041-020-00649-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-32445\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-32445\/v2","asserted-by":"object"}]},"ISSN":["1756-6606"],"issn-type":[{"value":"1756-6606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,10]]},"assertion":[{"value":"29 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing financial and non-financial interests in relation to this work. CM is an employee of M et P Pharma AG. However, the company did not play a role in any aspect of the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"111"}}